Douglas Allen Corley
#154,107
Most Influential Person Now
Douglas Allen Corley's AcademicInfluence.com Rankings
Douglas Allen Corleymedical Degrees
Medical
#3002
World Rank
#3451
Historical Rank
Gastroenterology
#67
World Rank
#69
Historical Rank
Douglas Allen Corleyphilosophy Degrees
Philosophy
#8653
World Rank
#12069
Historical Rank
Logic
#5679
World Rank
#7096
Historical Rank
Download Badge
Medical Philosophy
Douglas Allen Corley's Degrees
- Doctorate Medicine University of California, San Francisco
- Masters Public Health University of California, Berkeley
Why Is Douglas Allen Corley Influential?
(Suggest an Edit or Addition)Douglas Allen Corley's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Adenoma detection rate and risk of colorectal cancer and death. (2014) (758)
- A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. (2004) (556)
- Accuracy of Fecal Immunochemical Tests for Colorectal Cancer (2014) (549)
- Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. (2003) (540)
- Surveillance and survival in Barrett's adenocarcinomas: a population-based study. (2002) (507)
- Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. (2013) (414)
- Body Mass Index and Adenocarcinomas of the Esophagus or Gastric Cardia: A Systematic Review and Meta-analysis (2006) (391)
- Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. (2012) (383)
- Is Diabetes Mellitus an Independent Risk Factor for Colon Cancer and Rectal Cancer? (2011) (339)
- Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. (2007) (338)
- Abdominal obesity and body mass index as risk factors for Barrett's esophagus. (2007) (324)
- Body Mass Index and Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis (2006) (320)
- Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. (2003) (312)
- Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study (2017) (291)
- Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. (2010) (285)
- Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. (2010) (278)
- The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. (2002) (263)
- Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. (2018) (259)
- Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. (2001) (246)
- Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study (2016) (235)
- Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium (2012) (232)
- Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. (2013) (221)
- Adenoma detection rate and risk of colorectal cancer and death. (2014) (219)
- Octreotide for acute esophageal variceal bleeding: a meta-analysis. (2001) (215)
- Abdominal Obesity and the Risk of Esophageal and Gastric Cardia Carcinomas (2008) (211)
- Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis (2017) (195)
- Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. (2013) (183)
- Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening (2016) (181)
- A Genome-Wide Association Study Identifies New Susceptibility Loci for Esophageal Adenocarcinoma and Barrett’s Esophagus (2013) (179)
- Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett’s esophagus (2012) (176)
- Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018 (2015) (175)
- World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer. (2018) (173)
- Race, ethnicity, sex and temporal differences in Barrett’s oesophagus diagnosis: a large community-based study, 1994–2006 (2008) (166)
- BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia (2015) (158)
- Marked Multi-Ethnic Variation of Esophageal and Gastric Cardia Carcinomas within the United States (2004) (158)
- Screening Colonoscopy and Risk for Incident Late-Stage Colorectal Cancer Diagnosis in Average-Risk Adults (2013) (156)
- Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. (2012) (155)
- Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. (2012) (150)
- Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. (2014) (142)
- Gastroesophageal Reflux in Relation to Adenocarcinomas of the Esophagus: A Pooled Analysis from the Barrett’s and Esophageal Adenocarcinoma Consortium (BEACON) (2014) (141)
- Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms (2006) (131)
- Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. (2005) (127)
- Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States (2002) (123)
- Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium (2013) (123)
- The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett's Esophagus. (2012) (123)
- Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis (2016) (115)
- Can we improve adenoma detection rates? A systematic review of intervention studies. (2011) (115)
- Helicobacter pylori infection and the risk of Barrett’s oesophagus: a community-based study (2007) (108)
- Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus (2010) (107)
- Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium (2011) (106)
- Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems (2016) (104)
- Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. (2009) (103)
- Early Indicators of Prognosis in Upper Gastrointestinal Hemorrhage (1998) (103)
- Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. (2013) (100)
- Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency. (2017) (99)
- Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline (2019) (99)
- Prevention of vertical transmission of hepatitis B: an observational study. (2014) (98)
- New-onset diabetes and pancreatic cancer. (2006) (98)
- Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett’s Esophagus (2015) (93)
- Colorectal cancer deaths attributable to nonuse of screening in the United States. (2015) (92)
- Dietary Antioxidants, Fruits, and Vegetables and the Risk of Barrett's Esophagus (2008) (89)
- Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. (2004) (87)
- Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts (2020) (86)
- Diabetes, Hypertension and Hyperlipidemia: Prevalence Over Time and Impact on Long‐Term Survival After Liver Transplantation (2012) (85)
- Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system. (2015) (84)
- Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. (2010) (82)
- Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. (2015) (82)
- Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. (2008) (82)
- Diet and upper gastrointestinal malignancies. (2015) (81)
- Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests (2017) (80)
- The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. (2012) (78)
- Meta-Analysis of Antioxidant Intake and the Risk of Esophageal and Gastric Cardia Adenocarcinoma (2007) (78)
- Cumulative Burden of Colorectal Cancer-Associated Genetic Variants is More Strongly Associated With Early-onset vs Late-onset Cancer. (2019) (78)
- Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk. (2020) (74)
- Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model. (2015) (73)
- Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. (2016) (72)
- Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis (2014) (70)
- Lack of efficacy of TIPS for hepatopulmonary syndrome. (1997) (69)
- Long-term Risk of Colorectal Cancer and Related Death After Adenoma Removal in a Large, Community-based Population. (2020) (68)
- Developing a data infrastructure for a learning health system: the PORTAL network (2014) (62)
- Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis. (2013) (61)
- Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death. (2019) (60)
- Alcohol and the Risk of Barrett's Esophagus: A Pooled Analysis from the International BEACON Consortium (2014) (60)
- Timely follow‐up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium (2018) (59)
- Barrett's Esophagus and Medications that Relax the Lower Esophageal Sphincter (2006) (58)
- Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. (2016) (58)
- Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B 12 Deficiency (2013) (57)
- Serum Ghrelin Levels and Risk of Subsequent Adenocarcinoma of the Esophagus (2007) (56)
- Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. (2017) (56)
- Effects of Dietary Fiber, Fats, and Meat Intakes on the Risk of Barrett's Esophagus (2009) (56)
- Dietary patterns and the risk of Barrett's esophagus. (2008) (56)
- A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. (2012) (55)
- Cigarette smoking and the risk of Barrett’s esophagus (2009) (55)
- Helicobacter pylori and Gastroesophageal Reflux Disease: A Case–Control Study (2008) (53)
- Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status. (2016) (52)
- The Colorectal Cancer Screening Process in Community Settings: A Conceptual Model for the Population-Based Research Optimizing Screening through Personalized Regimens Consortium (2014) (52)
- Dietary guideline adherence for gastroesophageal reflux disease (2014) (52)
- Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings (2019) (51)
- Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model. (2015) (49)
- Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System (2016) (49)
- Does increased experience with laparoscopic cholecystectomy yield more complex bile duct injuries? (2012) (47)
- Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium (2018) (45)
- Survival Differences by Race/Ethnicity and Treatment for Localized Hepatocellular Carcinoma Within the United States (2009) (45)
- Effect of Sex, Age and Positivity Threshold on Fecal Immunochemical Test Accuracy: a Systematic Review and Meta-Analysis. (2019) (42)
- Proton Pump Inhibitor Use and Risk of Gastric, Colorectal, Liver, and Pancreatic Cancers in a Community-Based Population. (2020) (42)
- Building Data Infrastructure to Evaluate and Improve Quality: PCORnet. (2015) (42)
- Morbidity and Mortality After Surgery for Nonmalignant Colorectal Polyps: A 10-Year Nationwide Analysis (2019) (41)
- Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network (2019) (41)
- Chronic Kidney Disease and Risk of Renal Cell Carcinoma: Differences by Race (2015) (40)
- Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. (2014) (38)
- Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity. (2016) (37)
- Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection (2018) (36)
- Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases (2019) (35)
- Imputation of the Rare HOXB13 G84E Mutation and Cancer Risk in a Large Population-Based Cohort (2015) (35)
- Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study (2017) (34)
- Factors influencing variation in physician adenoma detection rates: a theory-based approach for performance improvement. (2016) (33)
- Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses. (2009) (32)
- Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma (2016) (31)
- Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett’s Esophagus (2016) (30)
- Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort (2017) (30)
- Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts (2020) (30)
- 969 Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018 (2015) (30)
- Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium (2016) (30)
- Overdiagnosis in Colorectal Cancer Screening: Time to Acknowledge a Blind Spot. (2018) (29)
- Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. (2014) (28)
- Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link? (2007) (28)
- Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach (2016) (28)
- Association of Azithromycin Use With Cardiovascular Mortality (2020) (28)
- A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma. (2015) (28)
- Aspirin and Nonsteroidal Anti-Inflammatory Drug Use and the Risk of Barrett’s Esophagus (2015) (28)
- Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study (2022) (27)
- Validation of the Hepatocellular Carcinoma Early Detection Screening (HES) Algorithm in a Cohort of Veterans with Cirrhosis. (2019) (27)
- Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers. (2019) (26)
- Colorectal Cancer Health Disparities and the Role of US Law and Health Policy. (2016) (25)
- Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors (2016) (25)
- Optimizing patient-reported outcome and risk factor reporting from cancer survivors: a randomized trial of four different survey methods among colorectal cancer survivors (2017) (25)
- Evaluating screening participation, follow-up and outcomes for breast, cervical and colorectal cancer in the PROSPR consortium. (2019) (24)
- Safety and Complications of Long-Term Proton Pump Inhibitor Therapy: Getting Closer to the Truth. (2019) (24)
- Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system (2017) (24)
- Diagnosis and predictors of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting. (2017) (24)
- Development and validation of an algorithm for classifying colonoscopy indication. (2015) (24)
- Endoscopist fatigue estimates and colonoscopic adenoma detection in a large community-based setting. (2017) (24)
- Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute’s PROSPR Consortium (2020) (23)
- MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium (2015) (23)
- Cancer Screening during COVID-19: A Perspective from NCI’s PROSPR consortium (2020) (23)
- Strategies to Improve Follow-up After Positive Fecal Immunochemical Tests in a Community-Based Setting: A Mixed-Methods Study (2019) (22)
- Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems (2017) (22)
- Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. (2015) (22)
- Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. (2016) (21)
- Racial disparities in renal cell carcinoma: a single‐payer healthcare experience (2016) (21)
- The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer? (2013) (21)
- A Newly Identified Susceptibility Locus near FOXP1 Modifies the Association of Gastroesophageal Reflux with Barrett's Esophagus (2015) (20)
- Metformin Use and Risk of Colorectal Adenoma after Polypectomy in Patients with Type 2 Diabetes Mellitus (2015) (20)
- Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps. (2020) (20)
- Accurate Identification of Colonoscopy Quality and Polyp Findings Using Natural Language Processing (2017) (20)
- Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature (2016) (20)
- Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States (2018) (20)
- Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease. (2015) (20)
- Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis. (2018) (19)
- Validity of diagnostic codes and laboratory tests of liver dysfunction to identify acute liver failure events (2015) (19)
- Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. (2015) (19)
- Association of Physician Adenoma Detection Rates With Postcolonoscopy Colorectal Cancer. (2022) (18)
- Cancer screening in the U.S. through the COVID-19 pandemic, recovery, and beyond (2021) (18)
- Iron Intake and Body Iron Stores as Risk Factors for Barrett's Esophagus: A Community-Based Study (2008) (18)
- Health care improvement and survivorship priorities of colorectal cancer survivors: findings from the PORTAL colorectal cancer cohort survey (2018) (18)
- Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett’s Esophagus (2015) (17)
- COVID-19 and Long-term Planning for Procedure-based Specialties During Extended Mitigation and Suppression Strategies (2020) (17)
- The Troublesome Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. (2017) (17)
- Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems (2018) (16)
- 9 Physician Adenoma Detection Rate Variability and Subsequent Colorectal Cancer Risk Following a Negative Colonoscopy (2013) (16)
- When Should Guidelines Change? A Clarion Call for Evidence Regarding the Benefits and Risks of Screening for Colorectal Cancer at Earlier Ages. (2018) (16)
- Accuracy of endoscopic databases for assessing patient symptoms: comparison with self-reported questionnaires in patients infected with the human immunodeficiency virus. (2000) (15)
- Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single‐payer healthcare system (2017) (15)
- Evaluation of upper gastrointestinal tract symptoms in patients infected with HIV (1999) (15)
- Colorectal-cancer screening--coming of age. (2013) (15)
- Polymorphisms Near TBX 5 and GDF 7 Are Associated With Increased Risk for Barrett ’ s Esophagus (14)
- Approaches for classifying the indications for colonoscopy using detailed clinical data (2014) (13)
- Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett’s Esophagus (2018) (13)
- Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program. (2017) (13)
- Survival with early diagnosis of invasive gastric mucormycosis in a heart transplant patient. (1997) (13)
- Dietary sugar/starches intake and Barrett’s esophagus: a pooled analysis (2017) (13)
- 414 Proton Pump Inhibitors, H2 Antagonists, and Risk of Hip Fracture: A Large Population-Based Study (2009) (13)
- A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors (2020) (12)
- Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort (2018) (12)
- No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. (2019) (12)
- Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing (2020) (12)
- Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis. (2016) (12)
- Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue (2017) (11)
- Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers (2015) (11)
- Risk stratification for colorectal cancer in individuals with subtypes of serrated polyps (2021) (11)
- Importance of determining indication for colonoscopy: implications for practice and policy original. (2014) (10)
- Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy (2013) (10)
- Comparison of Universal Versus Age-Restricted Screening of Colorectal Tumors for Lynch Syndrome Using Mismatch Repair Immunohistochemistry (2019) (10)
- Early Screening of African Americans (45-50 Years Old) in a Fecal Immunochemical Test-based Colorectal Cancer Screening Program. (2020) (10)
- Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma (2016) (10)
- Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett’s Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium (2015) (9)
- Barrett's esophagus: who should receive ablation and how can we get the best results? (2012) (9)
- Gastrointestinal bleeding and gastric outlet obstruction from Peutz-Jeghers polyposis. Diagnosis and treatment. (1997) (9)
- Validation of an Algorithm to Identify Patients at Risk for Colorectal Cancer Based on Laboratory Test and Demographic Data in Diverse, Community-Based Population. (2020) (9)
- Validation of the Updated Hepatocellular Carcinoma Early Detection Screening Algorithm in a Community-based Cohort of Patients With Cirrhosis of Multiple Etiologies. (2020) (9)
- Pleiotropic Analysis of Cancer Risk Loci on Esophageal Adenocarcinoma Risk (2015) (8)
- Association Between Levels of Hormones and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. (2019) (8)
- The future of colon cancer screening: what do we recommend and will it be too much, too little, or just right? (2011) (8)
- Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (2022) (8)
- Association between Improved Colorectal Screening and Racial Disparities. (2022) (8)
- Sex-Specific Genetic Associations for Barrett's Esophagus and Esophageal Adenocarcinoma. (2020) (8)
- Hemochromatosis Gene Status as a Risk Factor for Barrett’s Esophagus (2008) (8)
- Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia (2015) (8)
- Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction. (2021) (8)
- COVID-19: What Should Clinicians and Scientists Do and When? (2020) (7)
- Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium. (2016) (7)
- Pan-Cancer Study Detects Novel Genetic Risk Variants and Shared Genetic Basis in Two Large Cohorts (2019) (7)
- Diabetes in relation to Barrett’s esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett’s and Esophageal Adenocarcinoma Consortium (2019) (7)
- Time to Follow-up After Colorectal Cancer Screening by Health Insurance Type. (2019) (7)
- Food, the immune system, and the gastrointestinal tract. (2015) (7)
- Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer (2017) (7)
- Can You Stop Surveillance After Radiofrequency Ablation of Barrett's Esophagus? A Glass Half Full. (2013) (6)
- Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. (2020) (6)
- Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based Population (2022) (6)
- Collaborating on Data, Science, and Infrastructure: The 20-Year Journey of the Cancer Research Network (2019) (6)
- Gastroesophageal Reflux Frequency, Severity, Age of Onset, Family History and Acid Suppressive Therapy Predict Barrett Esophagus in a Large Population (2018) (6)
- Vertical Transmission of Hepatitis B Virus (2014) (6)
- Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations (2019) (5)
- Oral bisphosphonates and colorectal cancer (2017) (5)
- Colorectal Cancer Screening Participation Among Asian Americans Overall and Subgroups in an Integrated Health Care Setting with Organized Screening (2018) (5)
- Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting. (2019) (5)
- Colonoscopy Indication Algorithm Performance Across Diverse Health Care Systems in the PROSPR Consortium (2019) (4)
- Standardized reporting and management of suspicious findings on chest computed tomography is associated with improved lung cancer diagnosis in an observational study. (2020) (4)
- Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines (2022) (4)
- 175 Colonoscopy Delay After a Positive Fecal Test and Risk of Colorectal Cancer-Related Outcomes (2016) (4)
- Incidence rates of cardiovascular outcomes in a community‐based population of cancer patients (2019) (4)
- 691 – Increasing Physician Adenoma Detection Rate is Associated with a Reduced Risk of Post-Colonoscopy Colorectal Cancer (2019) (4)
- Primary Care Provider Beliefs and Recommendations About Colorectal Cancer Screening in Four Healthcare Systems (2020) (4)
- 90 Barrett's Esophagus Surveillance and Risk of Death From Esophageal Adenocarcinoma: A Case-Control Study (2010) (4)
- Gastroesophageal reflux disease (GERD) in the morbidly obese: A preoperative assessment (2003) (4)
- Advancing Diversity, Equity, and Inclusion in Scientific Publishing. (2021) (4)
- Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status (2017) (4)
- Cancer incidence in Barrett's esophagus: does it really matter, and who's counting anyway? (2008) (3)
- Association between surveillance and survival in Barrett's adenocarcinomas: A population-based study (2001) (3)
- Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test. (2017) (3)
- Rising Early-Onset Colorectal Cancer Incidence is Not an Artifact of Increased Screening Colonoscopy Use in a Large, Diverse Healthcare System. (2021) (3)
- Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma (2016) (3)
- Tumor characteristics and treatment in early-onset colorectal cancer. (2018) (3)
- Chemoprevention in Barrett's esophagus: are we there yet, are we there yet...? (2009) (3)
- Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies (2022) (3)
- Editors in Chief, Gastroenterology. (2020) (2)
- Mo1566 Screening Colonoscopy and Risk of Incident Late-Stage Colorectal Cancer Diagnosis in Average-Risk Adults: a Nested Case-Control Study (2013) (2)
- Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett's Esophagus? (2019) (2)
- Response to Li and Hopper. (2021) (2)
- Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network. (2019) (2)
- 1023 Impact of Variation in Screening Colonoscopy Quality on the Prevention of Colorectal Cancer Deaths. A Modelling Study (2013) (2)
- How should we select health professionals for studies? (2003) (2)
- 120 Fecal Immunochemical Test Performance Over Multiple Rounds of Annual Testing in an Outreach Screening Program (2014) (2)
- Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel. (2011) (2)
- 828 Adherence to Annual Fecal Immunochemical Testing in a Large, Community-Based Population (2013) (2)
- Esophageal metaplasia to adenocarcinoma: A population-based natural history (2003) (2)
- The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer (2020) (2)
- Influence of Telemedicine-first Intervention on Patient Visit Choice, Postvisit Care, and Patient Satisfaction in Gastroenterology (2020) (2)
- Marked global incidence variation of esophageal and gastric cardia adenocarcinomas: An international study (2001) (2)
- The association of bowel function, participation in life activities, and quality of life in rectal cancer survivors (2021) (2)
- Standardized Reporting and Management of Suspicious Findings on Chest CT Imaging Is Associated With Improved Lung Cancer Diagnosis in an Observational Study (2020) (2)
- Assessing bowel preparation quality using the mean number of adenomas per colonoscopy (2014) (2)
- Does Human Papillomavirus Cause Esophageal Adenocarcinoma? (2015) (2)
- 315 The Effect of Ambient Temperature on the Performance of Mailed Fecal Immunochemical Tests for Population-Based Screening (2014) (1)
- 689 – Risk of Colorectal Cancer and Related-Mortality Following Detection and Removal of Low- and High-Risk Adenomas (2019) (1)
- Risk of colorectal cancer and colorectal cancer mortality beginning ten years after a negative colonoscopy, among screen-eligible adults 76-85 years old. (2022) (1)
- Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studies (2022) (1)
- What makes a "good" colonoscopy quality indicator? (2016) (1)
- Promises and Potential Pitfalls of Shared Decision-making in Cancer Screening. (2019) (1)
- 931 INCIDENCE OF NONCARDIA GASTRIC ADENOCARCINOMA AFTER HELICOBACTER PYLORI ERADICATION IN A LARGE DIVERSE US POPULATION (2020) (1)
- Age-stratified prevalence and predictors of neoplasia among US adults undergoing screening colonoscopy in a national endoscopy registry. (2022) (1)
- Primary care visit use after positive fecal immunochemical test for colorectal cancer screening (2017) (1)
- Author Correction: Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases (2019) (1)
- Dietary fibre and risk of precancerous lesions and cancer of the oesophagus: a systematic review and meta-analysis (2013) (1)
- Biopsy of non-tumor sites after biopsy of a colorectal cancer is not associated with metachronous cancers: a case-control study. (2022) (1)
- Post-Colonoscopy Colorectal Cancer Etiologies in a Large Integrated United States Healthcare Setting. (2022) (1)
- Disparities in Colorectal Cancer Screening Rates Among Asian Subgroups in a Large Managed Care Organization (2015) (1)
- The learning health system: the tools are here, why aren't we moving forward? Embedding researchers and delivery science for accelerating health care change. (2021) (1)
- Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection (2019) (1)
- 744 Utilization and Accuracy of Biopsy in Patients With Hepatocellular Carcinoma in a Community Based Setting (2012) (1)
- Variation in Colorectal Cancer Stage and Mortality across Large Community-Based Populations: PORTAL Colorectal Cancer Cohort. (2020) (1)
- CLINICAL—ALIMENTARY TRACT A Combination of Esomeprazole and Aspirin Reduces Tissue Concentrations of Prostaglandin E2 in Patients With Barrett's Esophagus (2012) (1)
- ANALYSES OF PREVENTIVE CARE MEASURES WITH INCOMPLETE HISTORICAL DATA IN ELECTRONIC MEDICAL RECORDS: AN EXAMPLE FROM COLORECTAL CANCER SCREENING. (2020) (1)
- Body mass index and GERD: Is the association that huge? (2007) (1)
- Gastric acid-inhibiting medications and vitamin B12 deficiency--reply. (2014) (1)
- 783 – Long-Term Proton Pump Inhibitor Use and Risk of Gastrointestinal Cancers (2019) (1)
- Multitarget stool DNA testing for colorectal-cancer screening. (2014) (1)
- Abstract PR-03: Aspirin mediated downregulation of Warburg kinase AKT1 in patients with Barrett's esophagus: Implications in neoplastic transformation (2012) (1)
- Sa1864 Aspirin Downregulates Cell Survival and mTOR Effector pS6K in Barrett's Esophagus Patients: Data From a Randomized, Double-Blind, Phase II Chemoprevention Trial (2014) (0)
- Overall and Annual Post-Colonoscopy Colorectal Cancer Rates in a Large Integrated Healthcare Setting: A Cross-sectional Study. (2023) (0)
- Understanding racial disparities in renal cell carcinoma incidence: estimates of population attributable risk in two US populations (2019) (0)
- Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment Interval. (2022) (0)
- Mo2003 Long-Term Prospective Observational Study of Cancer Risk Among Pantoprazole Users (2015) (0)
- Accuracy of the Quantitative Fecal Immunochemical Test (FIT) for Colorectal Cancer and Advanced Adenoma Detection: An Updated Systematic Review and Meta-Analysis: Presidential Poster Award (2018) (0)
- Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States. (2023) (0)
- Variation in AdenomaDetection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening AMicrosimulationModel (2015) (0)
- Acknowledgment of 2008 Reviewers (2009) (0)
- Natural language processing for the accurate identification of colorectal cancer mismatch repair status in Lynch syndrome screening. (2020) (0)
- NUTRIENTS AND GASTROINTESTINAL MALIGNANCIES Diet and Upper Gastrointestinal Malignancies (2015) (0)
- 677: NARROWING THE GAP: COLORECTAL CANCER SCREENING COMPLETION BY RACE AND ETHNICITY SUBGROUPS AFTER OUTREACH STRATEGIES OF AN ORGANIZED SCREENING PROGRAM (2022) (0)
- Adverse Effects of Fecal-Based Colorectal Cancer Screening (2015) (0)
- 111 PREVALENCE AND PREDICTORS OF ADVANCED NEOPLASIA IN ADULTS YOUNGER THAN 50 YEARS UNDERGOING SCREENING COLONOSCOPY IN THE GIQUIC NATIONAL REGISTRY (2020) (0)
- Sa002 IMPACT OF THE COVID-19 PANDEMIC ON A LARGE ORGANIZED COLORECTAL CANCER SCREENING PROGRAM BASED ON FECAL IMMUNOCHEMICAL TESTING AND OPPORTUNISTIC COLONOSCOPY (2021) (0)
- Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network (2019) (0)
- Gastroenterology's Improvements and New Features. (2018) (0)
- University of Birmingham Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus (0)
- PS1-6: The Cancer Research Network: Creating New Possibilities for Cancer Prevention and Improved Cancer Outcomes (2013) (0)
- Tu1034 Impact of Fatigue on Colonoscopic Adenoma Detection in a Large Community-Based Managed Healthcare System (2014) (0)
- 251 Screening Colonoscopy and the Risk of Death From Right and Left Colon Cancers (2016) (0)
- 121 PERSONALIZED SCREENING STRATEGIES FOR COLORECTAL CANCER BASED ON GENETIC AND ENVIRONMENTAL RISK: A COST-EFFECTIVENESS ANALYSIS (2021) (0)
- Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B Deficiency (2015) (0)
- eQTL set-based association analysis identifies novel susceptibility loci for Barrett's esophagus and esophageal adenocarcinoma. (2022) (0)
- Paradigm-Shifting Research in Gastroenterology, Hepatology, and Nutrition: A Top 20 List of Articles Published in 2020. (2021) (0)
- Abstract B25: Black-white differences in colorectal cancer screening and incidence over time by age and sex (2017) (0)
- A comprehensive re-assessment of the association between vitamin D and cancer susceptibility using Mendelian randomization (2021) (0)
- Test performance metrics for breast, cervical, colon, and lung cancer screening: a systematic review (2023) (0)
- 120 WORLD ENDOSCOPY ORGANIZATION MODELED ANALYSIS OF POST-COLONOSCOPY COLORECTAL CANCER ETIOLOGIES IN A LARGE INTEGRATED HEALTHCARE SETTING (2021) (0)
- Mo1709 Characteristics of Interval Colorectal Cancers - A Retrospective Descriptive Analysis (2016) (0)
- Sa1082 Colorectal Cancer Screening Outreach Targeting Members Older than 75 Years of Age (2016) (0)
- Prevention of Vertical Transmission of Hepatitis B (2020) (0)
- 863 VALIDATION OF TOOLS FOR PREDICTING INCIDENT ADENOCARCINOMA OF THE ESOPHAGUS OR ESOPHAGOGASTRIC JUNCTION (2021) (0)
- Tu1129 Gluteofemoral Obesity Is Associated With a Reduced Risk of Barrett's Esophagus in Men: A Pooled Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium (2016) (0)
- Prevalence of DNA Biomarkers in Fecal Immunochemical Test Positive and Negative Colorectal Cancers: Presidential Poster: 2089 (2014) (0)
- Mo1607 - Organization of Colonoscopy Follow-Up of Positive Fecal Immunochemical Tests in a Large, Integrated Health System (2018) (0)
- Potential cost-effectiveness of aspirin (ASA) chemoprevention against esophageal adenocarcinoma (EAC) and colorectal cancer (CRC) in patients with Barrett's esophagus (BE) (2003) (0)
- Abstract 1446: Genetic risk factors for the development of multiple primary cancers (2022) (0)
- Associations Between Leptin, Ghrelin, and Barrett’s Esophagus: A Case-Control Study With Stratified Analyses Presidential Poster: 14 (2014) (0)
- Abstract 17951: The Effect of Proton Pump Inhibitors on Acute Coronary Syndrome Risk in Patients Receiving Clopidogrel after Coronary Drug Eluting Stent Placement in 10,677 Members of Kaiser Permanente Northern California (2012) (0)
- The Reply. (2017) (0)
- Community-Based Screening Colonoscopy Adenoma Detection Rates Vary Substantially by Patient Sex, Age, and Race/Ethnicity: Implications for Quality Assessment Programs (2011) (0)
- A population-based survey to assess the association between cannabis and quality of life among colorectal cancer survivors (2020) (0)
- Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings (2022) (0)
- Alcohol intake and risk of oesophageal adenocarcinoma a pooled analysis from the BEACON Constortium (2018) (0)
- Abstract CN06-03: Randomized double-blinded phase II trial of esomeprazole versus esomeprazole + two doses of aspirin in Barrett's esophagus patients (2011) (0)
- Provider- and Facility-Level Variation in Precancerous Cervical Biopsy Diagnoses (2023) (0)
- Large scale meta-analysis identifies new genetic risk loci for esophageal adenocarcinoma (EA) and the first EA risk locus independent of Barrett’s esophagus (2017) (0)
- 811: IMPACT OF THE COVID-19 PANDEMIC ON FECAL IMMUNOCHEMICAL TESTING, COLONOSCOPY SERVICES, AND COLORECTAL NEOPLASIA DETECTION IN A LARGE UNITED STATES COMMUNITY-BASED POPULATION (2022) (0)
- Sa1050 Prevalence of DNA Biomarkers in Fecal Immunochemical Test Positive and Negative Colorectal Cancers (2015) (0)
- Evaluating and Improving Cancer Screening Process Quality in a Multilevel Context: The PROSPR II Consortium Design and Research Agenda. (2022) (0)
- 314 Consequences of Delayed Diagnostic Colonoscopy Following a Positive Fecal Immunochemical Test (2014) (0)
- The implementation checklist: A pragmatic instrument for accelerating research‐to‐implementation cycles (2023) (0)
- Incidence of cardiovascular events in the real-world population of cancer patients treated with targeted therapies. (2014) (0)
- Su1666 – Predictors of Modifiable Failures to Screen for Colorectal Cancer At Appropriate Intervals Or Follow-Up on Abnormal Results (2019) (0)
- Tu1082 Factors Influencing Variation in Physician Adenoma Detection Rates: A Theory-Based Approach to Performance Improvement (2015) (0)
- Acknowledgment of 2009 Reviewers (2010) (0)
- 2239. Colorectal Cancer Screening Rates and Outcomes in HIV-Infected and HIV-Uninfected Individuals (2018) (0)
- BASIC AND TRANSLATIONAL—ALIMENTARY TRACT Polymorphisms Near TBX5 and GDF7 Are Associated With Increased Risk for Barrett's Esophagus (2015) (0)
- Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (2023) (0)
- Reducing Variation in the “Standard of Care” for Cancer Screening how this access benefits you. Your story matters (2016) (0)
- Oral Bisphosphonate Exposure and Risk of Esophageal and Gastric Cancer (2014) (0)
- The 75th Diamond Anniversary of Gastroenterology: 1943-2018. (2018) (0)
- 956 The Effect of an Organized Screening Program on Racial and Ethnic Disparities and Choice of Colorectal Cancer Screening Test (2014) (0)
- S252 Biopsy of Non-Tumor Sites After Biopsy of a Colorectal Cancer Is Associated With Metachronous Cancers: A Case-Control Study (2021) (0)
- Mo1966 Colorectal Cancer Screening Among Asian Subgroups in a Large Managed Care Organization (2015) (0)
- 1069 - Age as a Determinant of Lynch Syndrome Screening Performance Using Colorectal Cancer Immunohistochemistry in a Large Population-Based Program in the United States (2018) (0)
- Risk-stratified screening for colorectal cancer using genetic and environmental risk factors: A cost-effectiveness analysis based on real-world data. (2023) (0)
- Physician Adenoma Detection Rates and Colorectal Cancer-Reply. (2022) (0)
- Variability of Colonoscopist Adenoma Detection Rates in a Large Community-Based Population: Implications for Setting Average Detection Rates and Quality Initiatives (2011) (0)
- Approaches for classifying the indications for colonoscopy using detailed clinical data (2014) (0)
- 686 – Risk of Metachronous Colorectal Cancer Among Individuals with a History of Serrated Polyps – Data from a Large Integrated Healthcare System (2019) (0)
- The Dawning of a New Editorial Board for Gastroenterology. (2016) (0)
- Risk of Acute Liver Injury With Modern Antiretroviral Therapy (2016) (0)
- Declining Colectomy Rates for Nonmalignant Colorectal Polyps in a Large, Ethnically Diverse, Community-Based Population (2022) (0)
- 837 – Pilot Study of Early Screening in African Americans in an Organized Colorectal Cancer Screening Program Based on Fecal Immunochemical Testing (2019) (0)
- A Population-Based Survey to Assess Cannabis on Quality of Life among Colorectal Cancer Survivors (2020) (0)
- Abstract 881: Benchmarking genome-wide polygenic risk score development techniques in colorectal cancer risk prediction (2021) (0)
- Gastroenterology 2016-2022: The End of a Road But Continuation of a Journey. (2022) (0)
- PTU-031 The world endoscopy organisation consensus statements on post-colonoscopy and post-imaging colorectal cancer (2018) (0)
- Tu1088: COMPARISON OF CLINICAL CHARACTERISTICS AND PREDICTORS OF SPORADIC COLORECTAL CANCERS WITH VS. WITHOUT MICROSATELLITE INSTABILITY IN A DIVERSE U.S. POPULATION (2022) (0)
- Esophagectomy in patients with Barrett’s high grade dysplasia (1999) (0)
- 119 Impact of Adjusting for Patient Demographics on Physician Adenoma Detection Rates in a Large, Community-Based Setting (2014) (0)
- Limitations to Health Care Quality Measurement: Assessing Hospital Variation in Risk of Cardiac Events After Noncardiac Surgery. (2022) (0)
- 819: CHANGING TESTING PATTERNS AND PREVALENCE OF HELICOBACTER PYLORI OVER TWENTY YEARS IN A LARGE, DIVERSE, COMMUNITY-BASED U.S. POPULATION (2022) (0)
- Implementing a Multisite, Transdisciplinary Case-Control Study to Assess Effectiveness of Screening Colonoscopy for Preventing Death From Colorectal Cancer (SCOLAR) (2015) (0)
- Reply: To PMID 23673354. (2014) (0)
- COVID-19: Guidance for What Clinicians and Scientists Should Do and When (2021) (0)
- Chemoprevention with aspirin (ASA) or cyclooxygenase-2 inhibitors (COXIBs) in Barrett's esophagus (BE): A cost-effectiveness analysis (2003) (0)
- Erratum to: Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis (2014) (0)
- Mo1689 Long-Term Colorectal Cancer Incidence and Mortality for a Single Colonoscopy Versus Annual FOBT Is Influenced by Adherence; A Microsimulation Model Based on Observed National Colonoscopy Study Data (2016) (0)
- The authors respond. (2015) (0)
- 547 Use of Metformin and Risk of Recurrence of Colorectal Adenoma (2014) (0)
- S252 Presidential Poster Award Biopsy of Non-Tumor Sites After Biopsy of a Colorectal Cancer Is Associated With Metachronous Cancers: A Case-Control Study (2021) (0)
- Su1722 PREVALENCE OF COLONIC NEOPLASIA BY AGE AND INDICATION IN THE GIQUIC NATIONAL CLINICAL REGISTRY (2019) (0)
- Repeat Annual Fecal Immunochemical Testing Patterns in a Large Community-Based Integrated Healthcare Setting (2017) (0)
- Long-Term Impact of Colorectal Cancer Screening Using a Combination of Fecal Immunochemical Testing and Lower Bowel Endoscopy in a Large, Community-Based Integrated Healthcare Setting (2017) (0)
- Impact of a scalable training program on the quality of colonoscopy performance and risk of post-colonoscopy colorectal cancer. (2023) (0)
- 99 - Potentially Modifiable Factors in the Screening Process to Prevent Death from Colorectal Cancer (2018) (0)
- Mo1606 - Influence of Varying Quantitative Fecal Immunochemical Test Cut-offs on Sensitivity and Specificity for Colorectal Cancer Detection: A Community-Based Cohort Study (2018) (0)
- C1-1: Evaluation of Screening Colonoscopy per Patient Adenoma Count at a Large New York City Center Using Population-based Data (2014) (0)
- Validation of a genetic-enhanced risk prediction model for colorectal cancer in a large community-based cohort. (2023) (0)
- Tu1132 Cancer Incidence and Mortality Risks in a Large United States Barrett's Esophagus Cohort (2016) (0)
- Informative presence in electronic health record data: a challenge in implementing study exclusion criteria. (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Douglas Allen Corley?
Douglas Allen Corley is affiliated with the following schools:
